Pharmaceutical News

RSS

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical computing.

From TetraScience, Inc. 18 Jan 2022

WHO's recommendation provides two new options for treating COVID-19

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.

16 Jan 2022

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

A recent study revealed the effectiveness of 93% for the BNT162b2 vaccine against COVID-19 hospitalization among adolescents (12 to 18 years). This study included 179 patients at 19 sites in 16 states. The same group of researchers have extended their analysis to 31 locations in 23 states across the U.S. and recruited 266 more patients who had been hospitalized with SARS-CoV-2 infection.

13 Jan 2022

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

Researchers evaluated and modeled age-structured cases of SARS-CoV-2 infection, SARS-CoV-2 vaccination coverage, and breakthrough infections.

13 Jan 2022

KHN’s ‘What the Health?’: Dealing with drug prices

Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer's drug, to only patients participating in approved clinical trials.

13 Jan 2022

$Common osteoporosis medications protect against hip fracture during a 2-year drug holiday$

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

New research findings may help physicians and older adults with osteoporosis better manage their hip fracture risk while taking a break from their medication. The first-of-its-kind study, published in the Annals of Internal Medicine, found that the oral bisphosphonates risedronate and alendronate equally protect against hip fracture during a 2-year drug holiday.

13 Jan 2022

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

Specification of fictitious added benefit upon market access of orphan drugs not confirmed

In order to promote the development of drugs for rare diseases (orphan drugs) despite market risks, in Germany they are exempt from the regular benefit assessment procedure introduced in 2011 with the Act on the Reform of the Market for Medicinal Products (AMNOG).

13 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

Skin-related side effects may be an indicator that the cancer medications are working

Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects, most commonly affecting the skin.

12 Jan 2022

Long-term use of blood pressure medication could be contributing to kidney damage

New kidney research from the University of Virginia School of Medicine is raising concerns that long-term use of drugs commonly prescribed to treat high-blood pressure and heart failure could be contributing to kidney damage.

12 Jan 2022

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

A new study, posted to the medRxiv* preprint server, has focussed on the development of intranasal prophylaxis against SARS-CoV-2 infection.

11 Jan 2022

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

A common framework that standardizes health impact across diseases and their interventions can aid in identifying current shortcomings on a global scale, according to new research from Binghamton University, State University of New York.

11 Jan 2022

Third dose of mRNA COVID vaccine induces strong immunity in older adults

A new study describes the beneficial effects of a third dose of the COVID-19 mRNA vaccine in strengthening immunity among older adults.

11 Jan 2022

Clinics say California’s new Medicaid drug program will force them to cut services

California's sweeping new program to buy prescription drugs for its nearly 14 million Medicaid patients has alarmed health clinics that say they will lose money and have to cut services.

11 Jan 2022

Psychotropic drugs are commonly used by patients with heart disease, study shows

Antidepressants and other psychiatric medications are associated with an almost doubled risk of premature death in patients with heart conditions, according to research published today in the European Journal of Cardiovascular Nursing, a journal of the European Society of Cardiology (ESC).

11 Jan 2022

Optimal monoclonal antibodies against SARS-CoV-2 variants

Researchers screen different monoclonal antibodies to identify an optimal mAb with higher binding affinity to the receptor-binding domain of SARS-CoV-2.

10 Jan 2022

Biosimilars could drive down drug prices and lead to $38.4 billion savings

Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics from 2021 to 2025, according to a new RAND Corporation study.

10 Jan 2022

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Researchers screened BNT162b2 COVID-19 vaccine recipients and cloned broadly neutralizing antibodies from an elite vaccinee.

10 Jan 2022

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Researchers test the neutralizing action of a panel of eight therapeutic monoclonal antibodies against the SARS-CoV-2 Omicron (B.1.1.529) variant.

9 Jan 2022

Pharmaceutical News

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

WHO's recommendation provides two new options for treating COVID-19

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

KHN’s ‘What the Health?’: Dealing with drug prices

Common osteoporosis medications protect against hip fracture during a 2-year drug holiday

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Specification of fictitious added benefit upon market access of orphan drugs not confirmed

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Skin-related side effects may be an indicator that the cancer medications are working

Long-term use of blood pressure medication could be contributing to kidney damage

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

Third dose of mRNA COVID vaccine induces strong immunity in older adults

Clinics say California’s new Medicaid drug program will force them to cut services

Psychotropic drugs are commonly used by patients with heart disease, study shows

Optimal monoclonal antibodies against SARS-CoV-2 variants

Biosimilars could drive down drug prices and lead to $38.4 billion savings

Isolated antibodies from BNT162b2 vacinee effective against Omicron variant

Bolstering current therapeutic antibody treatments to help fight Omicron infections

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News